Long-Term Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Interim Results from the ADHERE+ Study (S16.002)

Assess the efficacy of subcutaneous (SC) efgartigimod PH20 (co-formulated with recombinant human hyaluronidase PH20) in chronic inflammatory demyelinating polyneuropathy (CIDP) in ADHERE+ (Interim analysis, data cutoff: February 16, 2024).

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211945
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Interim Results from the ADHERE+ Study (S16.002)

Thomas Skripuletz, Richard A. Lewis, Satoshi Kuwabara, Luís Querol et al.
Neurology
Peripheral Neuropathies and Disorders
article

Long-Term Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Interim Results from the ADHERE+ Study (S16.002)

Thomas Skripuletz, Richard A. Lewis, Satoshi Kuwabara, Luís Querol, Mark Stettner, Arne De Roeck, Kelly Gwathmey, Ryo Yamasaki, Jie Lin, Andoni Echaniz‐Laguna, Giuseppe Lauria, Jeffrey T. Guptill, Simon Rinaldi, Geoffrey Istas, Benjamin Van Hoorick, Chafic Karam, Jeffrey A. Allen, Niraja Suresh, Van Doorn Pieter
article en

Abstract

Assess the efficacy of subcutaneous (SC) efgartigimod PH20 (co-formulated with recombinant human hyaluronidase PH20) in chronic inflammatory demyelinating polyneuropathy (CIDP) in ADHERE+ (Interim analysis, data cutoff: February 16, 2024).

NeurologyVol. 104(7_Supplement_1)
Cedars-Sinai Medical Center (US), Chiba University (JP), Duke University (US), Fudan University (CN), Hospital de Sant Pau (ES), Erasmus MC (NL), Medizinische Hochschule Hannover (DE), California University of Pennsylvania (US), University of Oxford (GB), Kyushu University Hospital (JP), Essen University Hospital (DE), Lakeland Regional Medical Center (US), FHU Neurovasc (FR), Argenx (Belgium) (BE), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
Zero hunger
Openalex Percentile: Top 89%
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.